Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system

Lauren E. Haydu; John F. Thompson; Richard A Scolyer; Jeffrey E. Gershenwald

doi:10.1016/j.ejca.2019.01.103

Related publications

Editorial Material2018

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

Jeffrey E. Gershenwald, Richard A Scolyer

Corrigendum2018

Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

Jeffrey E. Gershenwald, Richard A Scolyer

Article2017

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Jeffrey E. Gershenwald, Richard A Scolyer, Kenneth R. Hess, Vernon K. Sondak, Georgina V. Long, Merrick I. Ross, Alexander J. Lazar, Mark B. Faries, John M. Kirkwood, Grant A. McArthur, Lauren E. Haydu, Alexander M.M. Eggermont, Keith T. Flaherty, Charles M. Balch, John F. Thompson

Article2020

Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma

Lauren E. Haydu, Serigne Lo, Jennifer L. McQuade, Rodabe N. Amaria, Jennifer A. Wargo, Merrick I. Ross, Janice N. Cormier, Anthony Lucci, Jeffrey E. Lee, Sherise D. Ferguson, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Jonathan R. Stretch, Patrick Hwu, Sapna P. Patel, Adi Diab, Michael K. Wong, Isabella C. Glitza Oliva, Hussein A. Tawbi, Matteo S. Carlino, Alexander M. Menzies, Georgina V. Long,

Article2025

Predicting Sentinel Node Positivity in Melanoma Patients: Personalized Tools Outperform National Comprehensive Cancer Network and American Joint Committee on Cancer–Based Criteria

Alexander H. R. Varey, Serigne Lo, Richard A Scolyer, John F. Thompson